Classic buy the rumor, sell the news. It’s ok. Healthy pullback imo. Doesn’t change the fact that we are on our way of becoming a good company. They’re lining things up. This news should help enable them to line up decent financing and/or a good partner/suitor down the road. The medical community WILL start to take notice. When that happens , analysts won’t be far behind. It’d be nice to see them appear on CNBC with the device to talk about it. Could happen in the not too distant future as they get out there and talk about the data.
News 
Market Data 
Discover 
AI
